Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma

• Can G. Leineweber,
• Can G. Leineweber,
• Can G. Leineweber,
• Miriam Rabehl,
• Miriam Rabehl,
• Anne Pietzner,
• Anne Pietzner,
• Nadine Rohwer,
• Nadine Rohwer,
• Nadine Rohwer,
• Michael Rothe,
• Maciej Pech,
• Bruno Sangro,
• Rohini Sharma,
• Chris Verslype,
• Bristi Basu,
• Christian Sengel,
• Jens Ricke,
• Nils Helge Schebb,
• Karsten-H. Weylandt,
• Karsten-H. Weylandt,
• Julia Benckert

Affiliations

Can G. Leineweber

Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany

Can G. Leineweber

Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany

Can G. Leineweber

Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Miriam Rabehl

Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany

Miriam Rabehl

Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany

Anne Pietzner

Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany

Anne Pietzner

Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany

Nadine Rohwer

Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany

Nadine Rohwer

Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany

Nadine Rohwer

Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany

Michael Rothe

Lipidomix, Berlin, Germany

Maciej Pech

Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany

Bruno Sangro

Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain

Rohini Sharma

Department of Surgery and Cancer, Imperial College London, London, United Kingdom

Chris Verslype

Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium

Bristi Basu

0Department of Oncology, University of Cambridge, Cambridge, United Kingdom

Christian Sengel

1Radiology Department, Grenoble University Hospital, La Tronche, France

Jens Ricke

2Department of Radiology, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany

Nils Helge Schebb

3Chair of Food Chemistry, Faculty of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany

Karsten-H. Weylandt

Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany

Karsten-H. Weylandt

Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany

Julia Benckert

4Department of Hepatology and Gastroenterology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt—Universität zu Berlin, Berlin, Germany